Dai Chihara, MD, PhD is an Associate Professor in the Department of Lymphoma and Myeloma at MD Anderson Cancer Center in Houston, TX USA. Dr. Chihara received his MD degree from Kobe University and completed residency, fellowships in hematology and oncology both in Japan and the United States. Dr. Chihara focuses on clinical research of lymphoma from outcomes research to clinical trials with particular focus on aggressive and indolent B-cell lymphomas. He has led multiple research projects utilizing clinical data and population-based cancer registry data to identify high risk populations with poor outcomes. Dr. Chihara is currently working on development of experimental therapeutics and discovering novel trial design and biomarkers in lymphoma through investigator initiated clinical trials at MD Anderson Cancer Center to address unmet needs for patients. Dr. Chihara has received many awards including ones from American Society of Hematology and the American Society of Clinical Oncology and serves as an editorial board member in reputable journals such as Annals of Lymphoma and BMC Cancer.